Pancreatic neuroendocrine tumours – new therapeutic concepts

Short review


Neuroendocrine tumours (NETs) are rare tumours with their clinical behaviour depending on the location of the primary and grade of differentiation. Recently, a number of randomised studies have been published focussing on pancreatic NETs which have demonstrated the efficacy of new therapeutic approaches including thyrosin-kinase inhibition and targetting the mTOR pathway. The objective of this review is to briefly sum up systemic treatment options in well differentiated pancreatic neuroendocrine tumours which are currently available.


Pancreatic neuroendocrine tumours Systemic treatment 

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Division of Oncology and cancer research, Department of Internal Medicine IMedical University of ViennaViennaAustria

Personalised recommendations